Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
21m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
21m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
45m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
45m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
45m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Sarepta Therapeutics Inc logo

Sarepta Therapeutics Inc

About

Sarepta Therapeutics Inc (NASDAQ:SRPT) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
Mar 25 2026
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Mar 24 2026
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Mar 19 2026
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
Mar 16 2026
Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

Financials

Revenue
$2.2 B
Market Cap
$2.44 B
EPS
-7.13

Community Chat

Ask AI

6ix6ixAIEvents